SK hynix Inc.
198.63USD
+13.0800 (+7.05%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $6.26▲ | $0 | 0 | 0 |
| Next quarter | $7.34▲ | $0 | 0 | 0 |
| Current year | $26.29▲ | $0 | 1 | 0 |
| Next year | $34.08▲ | $0 | 1 | 0 |
Beat in 1 of the last 1
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $4.87 | $90.62 | +85.75 (+1760.7%) |
11 ratings from 9 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Needham | Maintained | Buy | $200 $220 | Aug 24, 2026 |
| Wolfe Research | Initiated | Outperform | $200 | Aug 4, 2026 |
| RBC Capital | Initiated | Outperform | $200 | Aug 4, 2026 |
| Cantor Fitzgerald | Initiated | Overweight | $300 | Aug 4, 2026 |
| Rosenblatt | Initiated | Buy | $320 | Aug 4, 2026 |
| Needham | Initiated | Buy | $200 | Aug 4, 2026 |
| William Blair | Initiated | Outperform | — | Aug 4, 2026 |
| Stifel | Initiated | Buy | $240 | Aug 4, 2026 |
| Barclays | Maintained | Overweight | $330 $300 | Jul 30, 2026 |
| UBS | Initiated | Buy | $204 | Jul 30, 2026 |
| Barclays | Initiated | Overweight | $330 | Jul 14, 2026 |
No analyst notes on SKHY yet.
Analyst Ratings
13 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 9 | 1 | 0 | 0 | Buy1.79 |
| 1 mo ago | 2 | 3 | 1 | 0 | 0 | Buy1.83 |